TipRanks
Advertisement
Advertisement
Veracyte Acquisition of Convergent Genomics Bolsters Urology Franchise; Buy Rating Reiterated with Unchanged $69 Price Target
PremiumRatingsVeracyte Acquisition of Convergent Genomics Bolsters Urology Franchise; Buy Rating Reiterated with Unchanged $69 Price Target
24d ago
Veracyte Completes Convergent Genomics Acquisition to Expand Urology
Premium
Company Announcements
Veracyte Completes Convergent Genomics Acquisition to Expand Urology
24d ago
Veracyte acquires Convergent Genomics for $150M in cash upfront
Premium
The Fly
Veracyte acquires Convergent Genomics for $150M in cash upfront
24d ago
Veracyte price target lowered to $54 from $66 at Piper Sandler
PremiumThe FlyVeracyte price target lowered to $54 from $66 at Piper Sandler
2M ago
Veracyte price target lowered to $50 from $60 at Canaccord
Premium
The Fly
Veracyte price target lowered to $50 from $60 at Canaccord
2M ago
Midday Fly By: Apple sinks after guidance, Amazon’s AWS powers beat
Premium
The Fly
Midday Fly By: Apple sinks after guidance, Amazon’s AWS powers beat
2M ago
Veracyte: Strong Earnings Beat, Raised Guidance and Emerging Diagnostics Portfolio Support Durable Upside, Justifying Buy Rating
PremiumRatingsVeracyte: Strong Earnings Beat, Raised Guidance and Emerging Diagnostics Portfolio Support Durable Upside, Justifying Buy Rating
2M ago
Closing Bell Movers: Apple slides 6% after soft guidance
Premium
The Fly
Closing Bell Movers: Apple slides 6% after soft guidance
2M ago
Veracyte raises FY26 revenue view to $590M-$596M from $582M-$592M
Premium
The Fly
Veracyte raises FY26 revenue view to $590M-$596M from $582M-$592M
2M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―